The critically ill child with novel H1N1 influenza A: A case series

Justin L. Lockman, William A. Fischer, Trish M. Perl, Alexandra Valsamakis, David G. Nichols

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

OBJECTIVE:: To describe the presentation, course, and outcome of critically ill children with novel H1N1 influenza disease. DESIGN:: Retrospective case series. SETTING:: Pediatric intensive care unit in an urban tertiary academic center. PATIENTS:: Thirteen consecutive patients admitted between June 2009 and August 2009 and known or subsequently found to be infected with novel H1N1 influenza A. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Clinical, laboratory, and radiographic data were reviewed. The patients were predominantly male (62%), aged 5 months to 21 yrs, and most (92%) had known risk factors for severe disease. Direct fluorescent antibody testing had a high false-negative rate (62%) and delayed treatment in some cases. The respiratory illness presented clinically with both bronchoconstriction and alveolar consolidation to varying degrees. Bacterial superinfection occurred frequently (23%). Forty-six percent of patients required mechanical ventilation and 23% required inotropic support for hypotension. None of the patients in this series required extracorporeal membrane oxygenation. Intensive care unit length of stay did not differ between an early (within 48 hrs) oseltamivir treatment group (length of stay, 4.2 ± 4.4 days) vs. a late treatment group (length of stay, 6.8 ± 8.8 days). All patients survived to hospital discharge. CONCLUSIONS:: Underlying chronic illness (especially respiratory illness) seems associated with critical novel H1N1 influenza disease in children. Respiratory manifestations are highly variable among patients and within a single patient involving both bronchoconstriction and alveolar disease. Therapies must be individualized and rapidly adjusted. The duration of critical illness was not different between early and late treatment groups. Whether this is reflective of sample size or indicative of the importance of therapeutic intervention at any time early during infection in critically ill patients is unclear. Bacterial superinfection was more common than previously reported for seasonal influenza A. Moderate novel H1N1 influenza disease, including respiratory failure and hypotension, had 100% survival in our series.

Original languageEnglish (US)
Pages (from-to)173-178
Number of pages6
JournalPediatric Critical Care Medicine
Volume11
Issue number2
DOIs
StatePublished - Mar 1 2010

Fingerprint

Critical Illness
Human Influenza
Length of Stay
Superinfection
Bronchoconstriction
Hypotension
Therapeutics
Oseltamivir
Pediatric Intensive Care Units
Extracorporeal Membrane Oxygenation
Artificial Respiration
Respiratory Insufficiency
Sample Size
Intensive Care Units
Chronic Disease
Survival
Antibodies
Infection

Keywords

  • Critical illness
  • Influenza A virus, H1N1 subtype
  • Influenza, human
  • Intensive care units, pediatric
  • Mechanical ventilation
  • Superinfection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine

Cite this

The critically ill child with novel H1N1 influenza A : A case series. / Lockman, Justin L.; Fischer, William A.; Perl, Trish M.; Valsamakis, Alexandra; Nichols, David G.

In: Pediatric Critical Care Medicine, Vol. 11, No. 2, 01.03.2010, p. 173-178.

Research output: Contribution to journalArticle

Lockman, Justin L. ; Fischer, William A. ; Perl, Trish M. ; Valsamakis, Alexandra ; Nichols, David G. / The critically ill child with novel H1N1 influenza A : A case series. In: Pediatric Critical Care Medicine. 2010 ; Vol. 11, No. 2. pp. 173-178.
@article{a5529d25a09740c28f0690e2f18b26e4,
title = "The critically ill child with novel H1N1 influenza A: A case series",
abstract = "OBJECTIVE:: To describe the presentation, course, and outcome of critically ill children with novel H1N1 influenza disease. DESIGN:: Retrospective case series. SETTING:: Pediatric intensive care unit in an urban tertiary academic center. PATIENTS:: Thirteen consecutive patients admitted between June 2009 and August 2009 and known or subsequently found to be infected with novel H1N1 influenza A. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Clinical, laboratory, and radiographic data were reviewed. The patients were predominantly male (62{\%}), aged 5 months to 21 yrs, and most (92{\%}) had known risk factors for severe disease. Direct fluorescent antibody testing had a high false-negative rate (62{\%}) and delayed treatment in some cases. The respiratory illness presented clinically with both bronchoconstriction and alveolar consolidation to varying degrees. Bacterial superinfection occurred frequently (23{\%}). Forty-six percent of patients required mechanical ventilation and 23{\%} required inotropic support for hypotension. None of the patients in this series required extracorporeal membrane oxygenation. Intensive care unit length of stay did not differ between an early (within 48 hrs) oseltamivir treatment group (length of stay, 4.2 ± 4.4 days) vs. a late treatment group (length of stay, 6.8 ± 8.8 days). All patients survived to hospital discharge. CONCLUSIONS:: Underlying chronic illness (especially respiratory illness) seems associated with critical novel H1N1 influenza disease in children. Respiratory manifestations are highly variable among patients and within a single patient involving both bronchoconstriction and alveolar disease. Therapies must be individualized and rapidly adjusted. The duration of critical illness was not different between early and late treatment groups. Whether this is reflective of sample size or indicative of the importance of therapeutic intervention at any time early during infection in critically ill patients is unclear. Bacterial superinfection was more common than previously reported for seasonal influenza A. Moderate novel H1N1 influenza disease, including respiratory failure and hypotension, had 100{\%} survival in our series.",
keywords = "Critical illness, Influenza A virus, H1N1 subtype, Influenza, human, Intensive care units, pediatric, Mechanical ventilation, Superinfection",
author = "Lockman, {Justin L.} and Fischer, {William A.} and Perl, {Trish M.} and Alexandra Valsamakis and Nichols, {David G.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/PCC.0b013e3181ccedae",
language = "English (US)",
volume = "11",
pages = "173--178",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The critically ill child with novel H1N1 influenza A

T2 - A case series

AU - Lockman, Justin L.

AU - Fischer, William A.

AU - Perl, Trish M.

AU - Valsamakis, Alexandra

AU - Nichols, David G.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - OBJECTIVE:: To describe the presentation, course, and outcome of critically ill children with novel H1N1 influenza disease. DESIGN:: Retrospective case series. SETTING:: Pediatric intensive care unit in an urban tertiary academic center. PATIENTS:: Thirteen consecutive patients admitted between June 2009 and August 2009 and known or subsequently found to be infected with novel H1N1 influenza A. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Clinical, laboratory, and radiographic data were reviewed. The patients were predominantly male (62%), aged 5 months to 21 yrs, and most (92%) had known risk factors for severe disease. Direct fluorescent antibody testing had a high false-negative rate (62%) and delayed treatment in some cases. The respiratory illness presented clinically with both bronchoconstriction and alveolar consolidation to varying degrees. Bacterial superinfection occurred frequently (23%). Forty-six percent of patients required mechanical ventilation and 23% required inotropic support for hypotension. None of the patients in this series required extracorporeal membrane oxygenation. Intensive care unit length of stay did not differ between an early (within 48 hrs) oseltamivir treatment group (length of stay, 4.2 ± 4.4 days) vs. a late treatment group (length of stay, 6.8 ± 8.8 days). All patients survived to hospital discharge. CONCLUSIONS:: Underlying chronic illness (especially respiratory illness) seems associated with critical novel H1N1 influenza disease in children. Respiratory manifestations are highly variable among patients and within a single patient involving both bronchoconstriction and alveolar disease. Therapies must be individualized and rapidly adjusted. The duration of critical illness was not different between early and late treatment groups. Whether this is reflective of sample size or indicative of the importance of therapeutic intervention at any time early during infection in critically ill patients is unclear. Bacterial superinfection was more common than previously reported for seasonal influenza A. Moderate novel H1N1 influenza disease, including respiratory failure and hypotension, had 100% survival in our series.

AB - OBJECTIVE:: To describe the presentation, course, and outcome of critically ill children with novel H1N1 influenza disease. DESIGN:: Retrospective case series. SETTING:: Pediatric intensive care unit in an urban tertiary academic center. PATIENTS:: Thirteen consecutive patients admitted between June 2009 and August 2009 and known or subsequently found to be infected with novel H1N1 influenza A. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Clinical, laboratory, and radiographic data were reviewed. The patients were predominantly male (62%), aged 5 months to 21 yrs, and most (92%) had known risk factors for severe disease. Direct fluorescent antibody testing had a high false-negative rate (62%) and delayed treatment in some cases. The respiratory illness presented clinically with both bronchoconstriction and alveolar consolidation to varying degrees. Bacterial superinfection occurred frequently (23%). Forty-six percent of patients required mechanical ventilation and 23% required inotropic support for hypotension. None of the patients in this series required extracorporeal membrane oxygenation. Intensive care unit length of stay did not differ between an early (within 48 hrs) oseltamivir treatment group (length of stay, 4.2 ± 4.4 days) vs. a late treatment group (length of stay, 6.8 ± 8.8 days). All patients survived to hospital discharge. CONCLUSIONS:: Underlying chronic illness (especially respiratory illness) seems associated with critical novel H1N1 influenza disease in children. Respiratory manifestations are highly variable among patients and within a single patient involving both bronchoconstriction and alveolar disease. Therapies must be individualized and rapidly adjusted. The duration of critical illness was not different between early and late treatment groups. Whether this is reflective of sample size or indicative of the importance of therapeutic intervention at any time early during infection in critically ill patients is unclear. Bacterial superinfection was more common than previously reported for seasonal influenza A. Moderate novel H1N1 influenza disease, including respiratory failure and hypotension, had 100% survival in our series.

KW - Critical illness

KW - Influenza A virus, H1N1 subtype

KW - Influenza, human

KW - Intensive care units, pediatric

KW - Mechanical ventilation

KW - Superinfection

UR - http://www.scopus.com/inward/record.url?scp=77949476242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949476242&partnerID=8YFLogxK

U2 - 10.1097/PCC.0b013e3181ccedae

DO - 10.1097/PCC.0b013e3181ccedae

M3 - Article

C2 - 20048690

AN - SCOPUS:77949476242

VL - 11

SP - 173

EP - 178

JO - Pediatric Critical Care Medicine

JF - Pediatric Critical Care Medicine

SN - 1529-7535

IS - 2

ER -